Location
Industry
Stage
Size
status
Sort:

HAOFENG Medical (昊丰医疗)

China
Medical devices
Strategic investment / Sep ’26
HAOFENG Medical (昊丰医疗) is an interventional medical device CDMO service provider.
Tired of ads? Enjoy an ad-free experience by signing up.

fileAI

Singapore
Enterprise AI
Strategic investment / Aug ’26
fileAI, formerly known as Bluesheets, is an AI-native workflow automation platform and the world's only horizontal file processing agent, designed to automate complex, unstructured data workflows at scale.

Apate.ai

Australia
Conversational AI
Seed / $8.2M / Aug ’26
Apate.ai deploys conversational AI bots at scale to disrupt scams and protect financial institutions, telcos, and crypto exchanges.
Tired of ads? Enjoy an ad-free experience by signing up.

HicoreTech (海芯微)

China
Semiconductors
Series A / Aug ’26
HicoreTech (海芯微) is a company that focuses on the application solutions of digital signal processing (DSP) chips, Bluetooth audio application design, and audio solution design and promotion.

Voicetree

Australia
Language models
Grant / $70k / Aug ’26
Voicetree builds automatic concept graphs for flow-state context engineering, enabling the future of human-AI collaboration.
Tired of ads? Enjoy an ad-free experience by signing up.

HepaBio (合珀生物)

China
Biotechnology
Series A / Aug ’26
HepaBio (合珀生物) focuses on the research, development, and application of advanced 3D microtissue platform technologies, delivering comprehensive safety, efficacy, and metabolism evaluations to support preclinical drug development.

Dreamscale Labs

Australia
Physical AI
Grant / $100k / Aug ’26
DSL is an applied research company working towards a future of truly general robots.

Kronus

Australia
Enterprise AI
Grant / $70k / Aug ’26
Kronus is a development platform for building safety-critical systems with specialized workflows.

AusperBio (浩博医药)

China
Biopharmaceutical
Series C / $120M / Aug ’26
AusperBio (浩博医药) is a clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics.
Tired of ads? Enjoy an ad-free experience by signing up.